A
Atea Pharmaceuticals (AVIR)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atea Pharmaceuticals (AVIR)
Atea Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.... Read more
- USD3.23
- USD3.30
- USD3.21
- USD4.15
- 12.10%
- --
- 545.45k
- 411.26k
- 270M
- 2.46
- -5.00%
Stock News
3 hours ago
Trump says U.S. has launched attack on Iran nuclear sites as investors brace for ‘unpredictable spillovers’ across markets
MarketWatch
3 hours ago
CRWD, PANW, and SentinelOne Get Set to Secure Cybersecurity Market
Yahoo
5 hours ago
Boeing Deserves A Little More Love (Rating Upgrade)
SeekingAlpha
yesterday
Republican Party has nearly five times more cash on hand than the Democrats
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
